Introduction
============

Most invasive bacteria display two different lifestyles: whereas the free-floating planktonic bacteria' life style dominates, in some clinical settings, bacteria sensing hostile conditions adhere to biotic or abiotic surfaces and form biofilms ([@B39]). The planktonic to biofilm/sessile lifestyle transition is associated with important metabolic changes and self-production of proteins-lipids-exopolysaccharides-rich as well as extracellular DNA-containing extracellular matrix ([@B15]).

According to the National Institutes of Health, biofilms have an enormous impact on human medicine, accounting for over 80% of infectious processes in otherwise sterile tissue (s). Whereas the physiological inflammation is able to both clear invasive planktonic bacteria and to repair tissue damages insuring the return to tissue structural and functional homeostasis, this physiological inflammation does not operate in tissues experiencing sustained colonization by bacterial biofilms. Moreover, contrasting with planktonic bacteria that are cleared by commonly used antibiotics, provided that they do not harbor genetic resistance determinants, the majority of bacteria within the biofilms are resistant to these antibiotics ([@B33]).

In this review, our present understanding of the professional phagocyte sensors of microbial agonists expected to operate over the *in vivo* planktonic to biofilm lifestyle switch is briefly introduced. Transiently invasive planktonic bacteria are usually cleared by myeloid cells of either the neutrophil granulocyte lineage or/and by mononuclear phagocytes. However, the bilateral interactions engaged or not between sessile bacteria and the myeloid cells are still poorly studied. Until now, most experimentalists have conducted *in vitro* studies with sessile bacteria, exposing them to either one or the other myeloid cell lineage or both ([@B81]). This review focuses on recent developments obtained in rodent models to characterize inflammatory responses against *Staphylococcus aureus* or *Pseudomonas aeruginosa* sessile bacteria. A new experimental approach combining the mouse ear pinna model and the intravital imaging approach is proposed to analyze these innate immune responses at the dynamic level.

The Professional Phagocyte Sensors of Microbial Agonists Expected to Operate Over the *In Vivo* Planktonic to Biofilm Lifestyle Switch
======================================================================================================================================

The *in vivo* developmental transition from planktonic to sessile bacteria reflects a range of bilateral cross talks in the fluctuating dynamic tissue milieu colonized by the bacteria under study. At the earliest stage of this developmental transition, communications between key bacterial messengers as well as interactions between bacterial agonists and sensors displayed by the resident and recruited myeloid cells such as the professional phagocytes are initiated and renewed.

The Nucleotide-Based Second Messengers
--------------------------------------

The cyclic dinucleotides (c-di-NMPs) are recognized as Microbial Associated Molecular Patterns/MAMPs and induce a host type I interferon immune response prolonged by IFNγ production ([@B71]; [@B60]). Moreover, the c-di-NMPs play a central role in many bacterial species during the lifestyle transition ([@B71]). Using the *P. aeruginosa* model organism, [@B70] showed that the bacteria use c-di-GMP as a checkpoint during the different steps of biofilm development. There is indeed a direct correlation between high levels of c-di-GMP in the bacteria and biofilm formation, and between low levels of c-di-GMP and motility (planktonic phenotype). The c-di-GMP second messenger is used by *Escherichia coli* and *Salmonella enterica* serovar Typhimurium over their planktonic to biofilm developmental transition ([@B3]; [@B70]) whereas the c-di-AMP is used as a second messenger by other bacteria such as *S. aureus* ([@B14]).

The Guanosine tetraphosphate (ppGpp) and pentaphosphate (pppGpp), also called (p)ppGpp or alarmones are synthetized when bacteria are exposed to cells such as phagocytes in the infected tissue. Considered as bacterial signature of a so called stringent response, these alarmones represent intracellular signaling molecules known to participate to intracellular bacteria survival: [@B19] demonstrated that the stringent response is induced, *in vitro*, after *S. aureus* phagocytosis by neutrophil granulocytes or polymorphonuclears (PMN). The rapid (p)ppGpp synthesis leads to increased *psm* transcription and to participation of synthetized phenol soluble modulins (PSMs) concurring to bacteria survival after phagocytosis ([@B19]). Depicted as pro-inflammatory agents, the PSMs also account for the bacteria escape from the transient intracellular niche, followed either by bacteria survival inside the cytosol or by lysis of the cell, all these rapid processes contributing to damages of the *S. aureus-* hosting tissues ([@B19]; [@B50]).

The Quorum Sensing Circuit and Its Additional Regulators
--------------------------------------------------------

Quorum sensing (QS) is a cell-to-cell signaling process that allows bacteria to sense and process high cell densities. It involves the synthesis, release and accumulation of signaling molecules called auto-inducers (AIs) ([@B47]). At high concentrations, AIs induce cellular signaling cascades that notably control biofilm formation. The QS system of *S. aureus* called accessory gene regulator (Agr) has been extensively studied ([@B46]). With other regulators, it constitutes a complex regulatory network that, at any moment, either modifies AGR activity itself, or its downstream signaling or metabolic pathways. At the early stage of *S. aureus* developmental transition from planktonic to biofilm lifestyle, the low Agr concentration allows the production of inter-bacteria/intercellular adhesins whereas toxins' expression is repressed ([@B7]). Later, high levels of Agr induce biofilm structuration and dispersion by up-regulating the expression of the pro-inflammatory PSM molecules ([@B45]; [@B49]; [@B32]; [@B46]). Environmental factors also modulate the Agr function in *S. aureus*, with a well-described inhibitory effect of the reactive oxygen species (ROS) produced by innate immune cells ([@B32]).

Among other regulators that interact with the *agr* system at later stage of the biofilm development and maturation, the *[S]{.ul}. [a]{.ul}ureus* [e]{.ul}xoprotein (Sae) two-component system promotes the synthesis and secretion of leucocidins and other virulence determinants that actively participate to *S. aureus* survival after contact with PMN *in vitro* ([@B46]). Sae mutants have indeed a decreased capacity to resist to the PMN- clearing functions after contact ([@B82]; [@B76]; [@B46]).

Rodent Models to Study Inflammatory Responses to Biofilms *In Vivo*
===================================================================

In rodent laboratory models, the most rapidly recruited cells are phagocytes, namely the PMN. Over any local disruption of mouse tissue homeostasis, PMN stored in the bone marrow egress into the blood vascular bed. Through chemoattractants and cytokines produced by tissue resident mast cells and macrophages ([@B65]), the PMN rapidly cross the microvessels endothelial cells, reaching the extracellular compartment colonized by invasive bacteria. They represent the first wave of innate immune cells to be recruited from the blood circulation. Most often, PMN efficiently kill and degrade invasive planktonic bacteria by using different antimicrobial strategies: phagocytosis, production of ROS and antimicrobial peptides, as well as cytotoxic components released from their subcellular distinct granules. More recently, neutrophil extracellular traps (NETs) have been observed and included as an additional strategy ([@B10]). Among the *in vivo* models that allow characterization of the bilateral interactions co-engaged by PMN and sessile bacteria, we selected those relying on either *P. aeruginosa* or *S. aureus* (**Table [1](#T1){ref-type="table"}**).

###### 

Rodent models to study inflammatory responses to biofilms *in vivo*.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Organism                          Biomedical device whenever it is implanted   Tissue(s) where are either inoculated bacteria or implanted a bacteria--free or loaded device   Either bacteria inoculation or bacteria-loaded device delivery mode                              Inoculum dose (CFU)                               Reference
  --------------------------------- -------------------------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ------------------------------------------------- ------------------------------
  *P. aeruginosa*                   --                                           Lung (immobilized bacteria in alginate beads)                                                   Intra-tracheal                                                                                   6 × 10^6^ to 1,5 × 10^7^                          [@B30];\
                                                                                                                                                                                                                                                                                                                                    [@B9]; [@B2]; [@B73]; [@B27]

                                    --                                           Oropharyngeal aspiration of a bacterial suspension                                              Oropharyngeal                                                                                    1,5 × 10^7^                                       [@B57]

                                    Biofilm pre-colonized silicone implant       Implant inserted into the peritoneal cavity (hollow tubes)                                      Intraperitoneal                                                                                  --                                                [@B72]

                                    Biofilm pre-colonized silicone implant       Implant inserted into the peritoneal cavity (flat implant)                                      Intraperitoneal                                                                                  --                                                [@B12]

  *S. aureus*                       --                                           Diabetic mouse-based model allowing systemic invasion outcome                                   Intraperitoneal                                                                                  10^8^                                             [@B24]

  *P. aeruginosa* and *S. aureus*   --                                           Chronically wounded diabetic mouse model                                                        Topical application of bacteria onto a peripheral wound                                          10^4^ 2 × 10^5^, 2 × 10^6^, 2 × 10^7^             [@B79], [@B80]\
                                                                                                                                                                                                                                                                                                                                    [@B20]

  *S. aureus*                       Un-colonized silicon splint                  Chronically wounded diabetic mouse model                                                        Dermal application of bacteria onto the wounded surface                                          10^6^                                             [@B42]

  *P. aeruginosa*                   --                                           Chronic wound model                                                                             Subcutaneous injection of bacteria immobilized in alginate beads beneath a thermal skin lesion   10^6^                                             [@B69]

  *S. aureus*                       --                                           Air pouch model                                                                                 Inoculation of bacteria in a single pouch                                                        10^7^                                             [@B68]

  *S. aureus*                       --                                           Hematogenous model of septic arthritis initiated in murine knees                                Intravenous                                                                                      2 × 10^6^ 1,5 × 10^6^, 3 × 10^7^                  [@B13]\
                                                                                                                                                                                                                                                                                                                                    [@B74]

                                    Un-colonized orthopedic implant (K-wire)     Post-arthroplasty model (K-wire into the right-knee joint)                                      Inoculation of bacteria into the joint space containing the cut end of the implant               10^3^ 10^2^, 10^3^, or 10^4^10^3^10^3^ or 10^5^   [@B8]; [@B25]; [@B55]\
                                                                                                                                                                                                                                                                                                                                    [@B54]\
                                                                                                                                                                                                                                                                                                                                    [@B44]\
                                                                                                                                                                                                                                                                                                                                    [@B75]

                                    Un-colonized catheter inserted in a pouch    Catheter-related model                                                                          Intradermal inoculation of bacteria at proximity of the pouch containing the catheter            5 × 10^5^                                         [@B59]

                                    Un-colonized catheter                        Catheter-related model                                                                          Intradermal inoculation of bacteria into the catheter lumen                                      10^3^5 × 10^5^                                    [@B21], [@B22]\
                                                                                                                                                                                                                                                                                                                                    [@B66]

                                    Un-colonized orthopedic implant (K-wire)     Hematogenous implant-related bacteria colonization                                              Intravenous (tail vein) Intravenous (retroorbital sinus)                                         10^4^ to 10^9^ 10^6^, 5 × 10^6^, 10^7^            [@B58]\
                                                                                                                                                                                                                                                                                                                                    [@B78]

                                    Pre-colonized flat stainless steel wire      Orthopedic biofilm model                                                                        Tibial implant                                                                                   --                                                [@B43]

                                    Pre-colonized pin                            Prosthetic implant model                                                                        Tibial implant                                                                                   3 × 10^5^                                         [@B52],[@B53]

  *P. aeruginosa*                   Un-colonized polyethylene catheter           Ascending pyelonephritis model                                                                  Inoculation of bacteria into the bladder                                                         5 × 10^6^                                         [@B38]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Of note, the features of the biofilm-colonized devices condition the interaction profiles: whereas in devices of hollow type (catheter, silicon splint) bacterial biofilms are protected from the immune cells, on solid devices (K-wire, pin), the bacterial biofilms are directly exposed to the different waves of immune cells. Depending on the model used, many other parameters operate (listed in **Table [1](#T1){ref-type="table"}**). In most models, an intense and rapid accumulation of PMN is observed at the proximity of the biofilms ([@B77]; [@B52]; [@B68]; [@B40]; [@B78]), the PMN representing the most abundant population of recruited cells. Using a non- invasive bioluminescence-based approach, [@B8] showed that this recruitment is IL-1β dependent, as a 50% decrease in PMNs numbers was observed in the bacteria colonized knee joints of IL-1β deficient mice, as compared to wild-type mice. This PMN infiltration is increased when diabetic mice are treated with insulin in a bacteria-hosting wound, the latter incorporating actin and DNA from lysed PMN, which therefore contributes to the building of biofilms ([@B80]). Of note, a low PMN recruitment in the target tissues ([@B66]; [@B56]; [@B57]) can be also operating: in particular was noticed an association between the reduced PMN recruitment and the production of Filamentous Pf1-like bacteriophage (Pf phage) by *P. aeruginosa* ([@B57]). Taken globally, whatever the experimental conditions depicted in **Table [1](#T1){ref-type="table"}**, there is a need to capture more comprehensive information documenting, at least at the earliest stages, the *in vivo* dynamic interactions between bacteria and PMN.

Could mature biofilms' matrix components protect bacteria from activated PMN? PMN were indeed shown to be activated, *in vitro*, by bacterial DNA and polysaccharides components such as alginate, the measured outcome being an increase of their respiratory burst ([@B48]; [@B4]; [@B18]; [@B29]). *In vivo, P. aeruginosa* biofilm interactions with PMN lead to up regulation of the QS-dependent effectors such as rhamnolipids which cause PMN lysis ([@B1]). This shielding specific property of rhamnolipids is described in mouse models relying upon the intraperitoneal implant of pre-colonized silicone device ([@B72]) or on biofilm development in the respiratory tract ([@B9]; [@B27]). In these models, QS mutants are unable to produce rhamnolipids and are rapidly phagocytosed and cleared by PMN.

Monocytes/macrophages are other key actors recruited and sensing both the other inflammatory cells -e.g., PMN -as well as bacteria agonists. Under homeostatic conditions, circulating macrophage/monocytes qualified as classical/intermediate ones are continuously recruited from the blood and either mature into macrophages or remain as monocytes within tissues ([@B61]; [@B28]). In the skin, long- lived resident macrophages are also present and maintain their population by self-renewal ([@B61]; [@B28]). As for PMN, microbe-specific molecules participate to the rapid emigration of classical/intermediate monocytes in the extravascular space which contribute to the resolution of inflammation by recognizing and phagocytosing bacteria and dying cells, and by producing ROS and reactive nitrogen species (RNI) ([@B61]; [@B28]; [@B31]). Once PMNs experience apoptotic death, a second wave of monocytes qualified as non- classical monocytes contribute to the resolution of inflammation and repair of the disrupted tissue ([@B61]).

Only a few studies ([@B52]; [@B66]; [@B21], [@B22]; [@B55]; [@B13]; [@B59]; see **Table [1](#T1){ref-type="table"}**) assess the complex recruitment waves and networks of both PMN and monocyte subsets. Of note, an early wave of monocyte recruitment is sometimes predominant, as compared to PMN recruitment ([@B66]). Two main studies were conducted to monitor the abundance and functional features of monocyte/macrophage recruitment in *vivo* at specific time points after contact with biofilms. The biofilms' matrix components clearly modulate the functional properties of recruited cells. In a *S. aureus* pre-colonized catheter-based model, mobilized cells are mainly distant from the catheter and a non-significant proportion of F4/80^+^ macrophages are able to invade the biofilms. Cells present deeply into the biofilm rapidly die, therefore preventing phagocytosis of biofilm bacteria to be otherwise exerted by macrophages ([@B66]). A significant reduction of pro-inflammatory cytokines (IL-1β, TNF...) and chemokines (CXCL2, CCL2) production at the boundary of the biofilm- colonized tissue is also observed, associated with a reduced Nitric Oxide synthase (iNOS) induction and an increased arginase-1 expression. The authors conclude to a macrophage polarization toward a counter-inflammatory activated M2 phenotype and to fibrosis with MyD88- signaling as a major effector pathway regulating these two phenomena ([@B66]; [@B23]; [@B21]). In a lung experiencing colonization with phage Pf- producing *P. aeruginosa*, [@B57] also documented a M2 polarization profile. Taken globally, it appears that the macrophage M2 polarization and fibrosis do concur prolonging bacteria biofilm persistence, although the universal character of such responses remains to be assessed.

The Mouse Ear Pinna Dermis Imaged By Intra-Vital Confocal Microscopy At Steady and Not Steady State
===================================================================================================

Intra-vital microscopy is increasingly used in different biomedical research fields to study dynamic processes at the cellular level in their specific tissue environment. Compared to classical methods such as *ex vivo* histology or flow cytometry, intra-vital confocal microscopy live imaging allows dynamic interactions to be captured once fluorescent reporters are expressed by both the microbes and the laboratory mouse cell lineages with which are engaged, more or less durably, dynamic interactions.

Several skin-related models were described in the literature to study the immunobiology of biofilm infections by using classical approaches (**Table [1](#T1){ref-type="table"}**). In these models, the biofilm-loaded cutaneous sites were the back or the flank of animals, which represent unsuitable sites for intravital microscopy of cutaneous innate immune responses.

The ear pinnae is one of the most studied appendage in which are delivered microorganisms, enabling the observation of the early and either transient or prolonged dynamic interactions with resident or recruited myeloid cells ([@B6], [@B5]; [@B51]; [@B41]; [@B62]; [@B26]; [@B63]; [@B11]). As an imaging site, the ear presents several technical advantages such as the accessibility of the tissue, easy and fast protocols of preparation to perform imaging experiments and obtain reproducible results, and the possibility of imaging for long periods of time in blocks of 20--40 min ([@B34]).

The mouse ear pinna appendage harbors a thin epidermis and an underlying dermis, respectively avascularized and highly vascularized, which contain a broad range of lympho-myeloid cells ([@B26]). Using a multiphoton microscopy approach and quantitative flow cytometry, [@B67] elaborated a 3D immune cell atlas of mouse skin and compared the ear pinnae, dorsal back, footpad, and tail skin. Langerhans cells and dendritic epidermal T cells are present in the epidermis, whereas the dermis mainly harbors in the upper dermis myeloid cells such as dendritic cells, mast cells as well as lymphoid cells (αβT cells, γδT cells, and group 2 Innate Lymphoid Cells), and mainly resident macrophages in the deeper dermis ([@B64]; [@B67]). All these dermis-located immune cells are included in a collagen- and elastin- rich and more or less hyaluronan- rich extracellular matrix. In term of cell numbers, the specificities of the ear pinna cutaneous site are the following ones: the total leukocyte density is high, with around 4800 cells per mm^2^ and a majority of cells present in the dermis. Macrophages, dermal dendritic cells and mast cells represent the majority of ear dermal leukocytes with respectively around 6000 macrophages per mm^3^ and more than 2000 dermal dendritic cells and mast cells per mm^3^ ([@B67]). Of note, the ear pinna dermis presents two specificities regarding the presence of mast cells: their high prevalence and their perivascular localization, in close association to blood vessels, in contrast to dermal dendritic cells ([@B67]). By using intravital multi-photon microscopy, [@B41] showed that PMNs are present in the ear dermis of naive mice, but in small numbers, and patrol, as do dermal dendritic cells. Both cell lineages are likely surveying the presence of either epidermis-restricted microbiota derived agonists that reach the dermis or endogenous agonists through the sensors displayed at the plasma membrane or within the macropinocytosis/endosomal machinery.

The Mouse Ear Skin Model to Study the Dynamics of Innate Immune Responses Against Planktonic or Sessile *Staphylococcus aureus*
===============================================================================================================================

By combining intra-vital confocal microscopy approach and the mouse ear pinna infection model, inflammatory responses against biofilms could be analyzed for the first time at the dynamic level in the tissue environment. The **Figure [1](#F1){ref-type="fig"}** shows the schematic workflow of methods proposed to characterize and compare the innate immune responses against *S. aureus* planktonic and sessile bacteria. Transgenic mice with fluorescent immune cells visible in the skin such as Lysozyme-EGFP (circulating PMNs and monocytes, dermal macrophages), CD11c-EYFP (dermal dendritic cells, epidermal langherans cells) and Mcpt5-Cre+R26Y+ (dermal mast cells) mouse strains have been selected ([@B17]; [@B35]; [@B16]). The conditions to prepare bacteria inoculum will be set up. The planktonic inoculum will be obtained from an overnight culture of fluorescent *S. aureus* Lyo-S2 strain in Trypticase Soja broth ([@B37]). Biofilms will be generated from a planktonic culture incubated at 37°C under static conditions. After 24 h of incubation, biofilms will be gently collected (A). The first series of experiments will be performed with Lysozyme-EGFP mice inoculated into the ear tissue with the same number of CFU of either planktonic or sessile bacteria (B). Inoculum will be micro-injected in two injection points in the dermis of the ear pinna tissue with a nanofil syringe ([@B36]). At early time-points, mice will be anesthetized and the cellular recruitment will be analyzed by confocal microscopy at the injection points (C1a and C1b). The behavior of recruited or resident innate immune cells (moving speed, trajectory, distance covered) will be analyzed, as well as their specific interactions with bacteria. In parallel, additional groups of mice will be inoculated with planktonic or biofilm bacteria to perform quantitative analyzes over 14 days in the ear tissue and the cutaneous draining lymph node (auricular lymph node), i.e., determination of the phenotype of recruited cells (C2), of the cytokine levels (C3), and counting of bacteria in the target tissues (C4). The inflammation visible to the eye and macroscopic cutaneous lesions (skin necrosis) will be observed and compared.

![The three steps' workflow proposed for extracting, post either *Staphylococcus aureus* planktonic or biofilm delivery, specific immune signatures displayed by mouse myeloid cells. **(A)** Inoculum preparation *in vitro*. **(B)** Inoculum micro-injection in the ear pinna of mouse (10^7^ UFC of either planktonic or sessile bacteria). (C1a) Real time imaging of the ear pinna of a LysM-EGFP transgenic mouse harboring fluorescent phagocytes and fluorescent *S. aureus* bacteria by confocal microscopy. (C1b) Massive recruitment of GFP+ cells post-injection in the upper dermis of the ear pinna of a mouse inoculated with *S. aureus* sessile or planktonic bacteria. (C2), (C3), (C4) Quantitative analyses in the ear pinna and the auricular lymph node to determine (C2) the phenotype of recruited cells, (C3) the cytokine levels and (C4) the bacteria counts.](fmicb-08-02309-g001){#F1}

Conclusion
==========

The objective of the review was to highlight the requirement of developing new *in vivo* models to analyze, at the early stage of infection, the dynamics of innate immune responses against *S. aureus* planktonic or sessile bacteria. A new experimental approach in the field combining the mouse ear pinna model and the intravital imaging approach is proposed. The long term objectives are to use this model as a pre-clinical model to test necessary new therapeutic approaches targeting the host immune system, as proposed initially by [@B22].
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